Increased NO production in lysinuric protein intolerance

L. Mannucci, F. Emma, M. Markert, C. Bachmann, O. Boulat, R. Carrozzo, G. Rizzoni, C. Dionisi-Vici

Research output: Contribution to journalArticle

Abstract

Lysinuric protein intolerance (LPI) is a disorder of dibasic amino acid transport secondary to mutation of the SLC7A7 gene characterized by renal failure, pulmonary alveolar proteinosis, lupus-like autoimmune symptoms and usually increased plasma citrulline. In order to better understand the underlying mechanism, we studied the plasma and urinary nitrite/nitrate (NO2-/NO3-) concentrations in three LPI patients and the in vitro NO2- production in cultured fibroblasts. Our data show that NO2- levels are increased in the plasma of patients with LPI. Similarly, NO2- release in the medium of cultured fibroblasts was increased. On this basis, we hypothesize that some of the poorly understood clinical signs of LPI could be related to the activation of the NO-citrulline pathway.

Original languageEnglish
Pages (from-to)123-129
Number of pages7
JournalJournal of Inherited Metabolic Disease
Volume28
Issue number2
DOIs
Publication statusPublished - Jan 2005

ASJC Scopus subject areas

  • Endocrinology
  • Genetics
  • Genetics(clinical)

Fingerprint Dive into the research topics of 'Increased NO production in lysinuric protein intolerance'. Together they form a unique fingerprint.

  • Cite this